Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. - Belouin SJ; Averill LA; Henningfield JE; Xenakis SN; Donato I; Grob CS; Berger A; Magar V; Danforth AL; Anderson BT (Neuropharmacology, 2022)